Article
Gene expression profiling of glucocorticoid-inhibited osteoblasts
1 Aug 2004
Abstract excerpt
Glucocorticoid (GC) treatment for the management of autoimmune and inflammatory diseases is associated with decreased bone formation and increased risk for fracture. In MC3T3-E1 cell cultures, 0.1-1 microM dexamethasone (DEX) arrests development of the osteoblast phenotype when administration commences at a commitment stage around the time of confluency. To gain new insights into GC-induced osteoporosis, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
